- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02441725
Validation of the 1-minute Sit-to-stand Test in Patients With COPD (STAND-UP)
1-minute Sit-to-stand Test: A Multicentre Validation Study of a Simple Exercise Capacity Test in Patients With Chronic Obstructive Pulmonary Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Exercise capacity is a strong predictor for mortality, exacerbations and health-related quality of life (HRQL) in patients with chronic obstructive pulmonary disease (COPD). The 1-minute sit-to-stand test (1-min STS test) is a promising exercise capacity test that is simple to conduct and requires few resources.
This study will provide an in-depth validation of the 1-min STS test, specifically evaluating the tests reliability, validity, responsiveness to change and minimal clinically important difference. The study will also assess the predictive properties of the 1-min STS test with regards to detecting exacerbations, as well as identify patterns of physical activity and patient-reported symptoms of exacerbations.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zurich, Switzerland, 8001
- University of Zurich
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- COPD diagnosis according to GOLD criteria; post bronchodilator FEV1/FVC<70%
- Male and female patients ≥40 years of age
- Able to do at least 5 repetitions in the 1-min STS test at baseline assessment
- Written informed consent by the participant
Exclusion Criteria:
- Lower limb joint surgery in the preceding 3 months
- Too unstable medically to perform exercise tests
- Predominant neurological or musculoskeletal limitation to walking
- Cognitive reading impairment and/or difficulties managing the eDiary and step-counter
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Pulmonary Rehabilitation Patients
Validation of the 1-minute sit-to-stand test; for participants who consent including a extended daily assessment period of physical activity and patient-reported symptoms of exacerbations: Male and female COPD inpatients (≥40 years of age) from two pulmonary rehabilitation clinics (Klinik Barmelweid and Zürcher Höhenklinik Wald) |
Validation of the 1-minute sit-to-stand test in a COPD patient population
|
|
Other: Acute Care Hospital Patients
Validation of the 1-minute sit-to-stand test, including daily assessment of physical activity and patient-reported symptoms of exacerbations: Male and female COPD inpatients from two acute care hospitals (≥40 years of age; Stadtspital Waid and Spital Uster) |
Validation of the 1-minute sit-to-stand test in a COPD patient population
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
1-minute sit-to-stand test
Time Frame: Change from baseline after pulmonary rehabilitation programme
|
Number of repetitions performed in the 1-minute sit-to-stand test
|
Change from baseline after pulmonary rehabilitation programme
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
5-repetition sit-to-stand test
Time Frame: Change from baseline after pulmonary rehabilitation programme
|
Time taken to perform 5 sit-to-stand repetitions
|
Change from baseline after pulmonary rehabilitation programme
|
|
6-minute walk test
Time Frame: Change from baseline after pulmonary rehabilitation programme
|
Distance walked in 6 minutes
|
Change from baseline after pulmonary rehabilitation programme
|
|
Quadriceps maximal voluntary contraction force
Time Frame: Change from baseline after pulmonary rehabilitation programme
|
Change from baseline after pulmonary rehabilitation programme
|
|
|
Chronic Respiratory Questionnaire
Time Frame: Change from baseline after pulmonary rehabilitation programme
|
Change from baseline after pulmonary rehabilitation programme
|
|
|
Hospital Anxiety and Depression Scale
Time Frame: Change from baseline after pulmonary rehabilitation programme
|
Change from baseline after pulmonary rehabilitation programme
|
|
|
COPD Assessment Test
Time Frame: Change from Baseline after pulmonary rehabilitation programme
|
Change from Baseline after pulmonary rehabilitation programme
|
|
|
Baseline Dyspnoea & Transition Dyspnoea Index
Time Frame: Change from baseline after pulmonary rehabilitation programme
|
Change from baseline after pulmonary rehabilitation programme
|
|
|
Feeling Thermometer
Time Frame: Change from baseline after pulmonary rehabilitation programme
|
Change from baseline after pulmonary rehabilitation programme
|
|
|
Oxygen consumption (VO2)
Time Frame: Change from baseline (pre-exercise test) during and after test
|
Change from baseline (pre-exercise test) during and after test
|
|
|
Carbon dioxide production (VCO2)
Time Frame: Change from baseline (pre-exercise test) during and after test
|
Change from baseline (pre-exercise test) during and after test
|
|
|
Respiratory exchange ratio (RER)
Time Frame: Change from baseline (pre-exercise test) during and after test
|
Change from baseline (pre-exercise test) during and after test
|
|
|
Minute ventilation (VE)
Time Frame: Change from baseline (pre-exercise test) during and after test
|
Change from baseline (pre-exercise test) during and after test
|
|
|
Heart Rate
Time Frame: Change from baseline (pre-exercise test) during and after test
|
Change from baseline (pre-exercise test) during and after test
|
|
|
Blood oxygen saturation
Time Frame: Change from baseline (pre-exercise test) during and after test
|
Change from baseline (pre-exercise test) during and after test
|
|
|
Symptoms of exacerbations
Time Frame: Daily course over 3 months
|
The EXAcerbations of Chronic Pulmonary Disease Tool (EXACT)
|
Daily course over 3 months
|
|
Physical activity
Time Frame: Daily course over 3 months
|
As measured by a pedometer
|
Daily course over 3 months
|
|
Localisation
Time Frame: Daily course over 3 months
|
As measured by GPS information
|
Daily course over 3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Anja Frei, pHd, University of Zurich, Epidemiology, Biostatistics and Prevention Institute
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STAND-UP Study
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Disease, Chronic Obstructive
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
Strados Labs, Inc.WithdrawnChronic Obstructive Pulmonary Disease (COPD)United States
-
Pulmatrix Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
Clinical Trials on 1-minute sit-to-stand test
-
University of ZurichCompletedHealthy IndividualsSwitzerland
-
Centro Universitário Augusto MottaRecruitingHeart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IV | Heart Failure; With DecompensationBrazil
-
University Hospital, GrenobleCompletedIdiopathic Pulmonary FibrosisFrance
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Universidad Católica San Antonio de MurciaCompleted
-
Boston Children's HospitalCompleted
-
Groupe Hospitalier du HavreCompleted
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Hacettepe UniversityUnknownExercise Capacity | Cystic Fibrosis in ChildrenTurkey
-
Royal Brompton & Harefield NHS Foundation TrustKing's College LondonCompleted